Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03987243 · ClinicalTrials.gov registry record · NA

Mobile and Remote Monitoring of Seating Pressure for Wheelchair Users With SCI

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03987243: Completed NA study, sponsored by Mayo Clinic.

NCT03987243 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03987243, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

This study will examine two interventions to increase weight shifts, overall trunk movement, and self-efficacy related to pressure ulcer prevention in wheelchair users with a spinal cord injury (SCI).

Primary Outcome

The primary outcome variable, trunk movement, will be defined by the percentage of the day with active trunk movement.

Interventions

  • BEHAVIORAL Structured Pressure Ulcer Prevention Education
  • OTHER Mobile Seat Interface Pressure Mapping System (IPM)

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2017-02-14
Est. Completion 2017-09-11
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03987243 record still lists

NCT03987243 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Structured Pressure Ulcer Prevention Education is the first listed.

NCT03987243 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03987243 about?

NCT03987243 is a clinical study titled "Mobile and Remote Monitoring of Seating Pressure for Wheelchair Users With SCI". This study will examine two interventions to increase weight shifts, overall trunk movement, and self-efficacy related to pressure ulcer prevention in wheelchair users with a spinal cord injury (SCI).

What is the current status of trial NCT03987243?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2017-02-14. Estimated completion is 2017-09-11.

What interventions are being tested in trial NCT03987243?

The interventions under investigation include: Structured Pressure Ulcer Prevention Education (BEHAVIORAL), Mobile Seat Interface Pressure Mapping System (IPM) (OTHER).

Who is sponsoring clinical trial NCT03987243?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03987243's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03987243, the US trial registry maintained by the National Library of Medicine. NCT03987243 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.